Method for inactivating mold spores

US12102089B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12102089-B2
Application numberUS-202218048579-A
CountryUS
Kind codeB2
Filing dateOct 21, 2022
Priority dateNov 3, 2017
Publication dateOct 1, 2024
Grant dateOct 1, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to inactivating mold spores in a beverage using pasteurization in the presence of natamycin and to a beverage comprising natamycin and mycosamine.

First claim

Opening claim text (preview).

The invention claimed is: 1. A beverage having a pH of from 2.0 to 4.0 when measured at 20±2° C., wherein the beverage comprises an antifungal agent consisting of an effective amount of natamycin and mycosamine; and wherein mold spores of Aspergillus in the beverage are inactivated. 2. The beverage according to claim 1 , wherein the amount of each of natamycin and mycosamine in the beverage is from 0.1 to 100 ppm based on the total weight of said beverage. 3. The beverage according to claim 2 , wherein the amount of each of natamycin and mycosamine in the beverage is from 0.2 to 50 ppm based on the total weight of the beverage. 4. The beverage according to claim 3 , wherein the amount of each of natamycin and mycosamine in the beverage is from 0.3 to 25 ppm based on the total weight of the beverage. 5. The beverage according to claim 4 , wherein the amount of natamycin in the beverage is from 10 to 20 ppm based on the total weight of the beverage. 6. The beverage according to claim 5 , wherein the amount of natamycin in the beverage is about 10 ppm based on the total weight of the beverage. 7. The beverage according to claim 1 , wherein the beverage is selected from the group consisting of iced tea, flavored water, fruit juice, a carbonated beverage, and lemonade. 8. The beverage according to claim 1 , wherein the beverage is pasteurized. 9. The beverage according to claim 1 , wherein the beverage comprises at least one additional compound selected from the group consisting of an acidity regulator, an anticaking agent, an antifoaming agent, an antioxidant, a color, a color retention agent, a surfactant, an emulsifier, an additional preservative, and a dispersant. 10. The beverage according to claim 1 , wherein the beverage is microbially stable. 11. The beverage according to claim 1 , wherein the natamycin is present in an amount of less than 0.04 mg/L and the mycosamine is present in an amount of 2 mg/L. 12. A beverage comprising an antifungal agent consisting of an effective amount of natamycin and mycosamine, wherein the beverage is produced by subjecting the beverage having a pH of from 2.0 to 4.0, measured at 20±2° C. to a temperature of from 50° C. to 90° C. in the presence of natamycin and mycosamine; and wherein mold spores of Aspergillus in the beverage are inactivated. 13. The beverage according to claim 12 , wherein the temperature is from 65° C. to 85° C. 14. The beverage according to claim 12 , wherein the temperature is from 80° C. to 90° C. 15. The beverage according to claim 12 , wherein the amount of each of natamycin and mycosamine in the beverage is from 0.1 to 100 ppm based on the total weight of said beverage. 16. The beverage according to claim 12 , wherein the natamycin is present in an amount of less than 0.04 mg/L and the mycosamine is present in an amount of 2 mg/L. 17. The beverage according to claim 12 , wherein the beverage is selected from the group consisting of iced tea, flavored water, fruit juice, a carbonated beverage, and lemonade. 18. The beverage according to claim 12 , wherein the beverage comprises at least one additional compound selected from the group consisting of an acidity regulator, an anticaking agent, an antifoaming agent, an antioxidant, a color, a color retention agent, a surfactant, an emulsifier, an additional preservative, and a dispersant. 19. The beverage according to claim 12 , wherein the beverage is microbially stable.

Assignees

Inventors

Classifications

  • Sugars; Derivatives thereof · CPC title

  • Organic compounds containing hetero rings · CPC title

  • by addition of preservatives · CPC title

  • A01N43/90Primary

    having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12102089B2 cover?
The invention relates to inactivating mold spores in a beverage using pasteurization in the presence of natamycin and to a beverage comprising natamycin and mycosamine.
Who is the assignee on this patent?
Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification A01N43/90. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).